fbpx
QQQ
+ 1.24
303.04
+ 0.41%
DIA
+ 2.49
297.52
+ 0.83%
SPY
+ 3.11
363.56
+ 0.85%
TLT
-2.31
159.82
-1.47%
GLD
-0.51
173.33
-0.3%

IntelGenx And Heritage Cannabis Holdings Partner To Produce CBD Filmstrip Products

October 30, 2020 12:52 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

IntelGenx Corp. (TSXV:IGX) (OTCQB:IGXT) has partnered with Canadian medical cannabis producer Heritage Cannabis Holdings Corp. to produce filmstrip products containing CBD.

The filmstrips will be about the size of a postage stamp and contain 10 milligrams of CBD for distribution to the Canadian and Australian markets. The strips, which employ IntelGenx's proprietary VersaFilm technology, are placed underneath the tongue where the CBD is released and rapidly absorbed into the bloodstream. IntelGenx's VersaFilm technology is designed to offer a fast-acting, convenient and discrete alternative to traditional oral medications, such as tablets and pills.

Heritage will supply the CBD and IntelGenx will manufacture the strips at facility, under Canadian GPP conditions.

IntelGenx operates the only Health Canada-licensed and GMP compliant facility for pharmaceutical film manufacturing and received a cannabis micro-processing license from Health Canada in June.

The companies also have the option to further develop both CBD and THC products in the future.

IntelGenx will receive a manufacturing margin and double-digit royalties on the gross margin-based on product sales. The deal extends IntelGenx's development efforts in the adult- and medical use cannabis markets.

IntelGenx also has an exclusive worldwide marketing and distribution agreement with Tilray for non-CBD cannabis-infused VersaFilm® oral film products.

"We believe our VersaFilm technology holds great promise as a convenient and discrete delivery method for patients and consumers worldwide, particularly as markets move away from combustible products," IntelGenx CEO Horst Zerbe said. "We look forward to working with Heritage on these strips and to potentially developing a long-term relationship that will bring additional new products to market."

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

 


Related Articles

The Week In Cannabis: MORE Act Passes, UN Vote, Joe Rogan, Will.i.am, Aphria, Canopy And Earnings

It was a historic week for cannabis. read more

Sweet Dirt Expands In Maine, Opens Adult-Use Cannabis Store In Waterville

Cannabis company Sweet Dirt is poised to launch the first out of four adult use cannabis retail locations in Central and Southern Maine. The new store — located at 475 Kennedy Memorial Drive in Waterville, Maine — will open on Wednesday, Dec. 9. The ribbon-cutting ceremony is scheduled for Monday, Dec. 7. read more

No One Size Fits All: Cannabis Experts Discuss Merits Of Capped, Uncapped Markets

Cannabis regulations vary by state, with license caps serving as one of the more glaring differences. Depending where you are, caps may or may not be imposed on various points in the supply chain, which can include limits on ownership, production, delivery or retail. read more

MedC Biopharma Corporation Launches $3M Private Placement Offering

Skin oncology medication manufacturer MedC Biopharma Corp. is launching its $3 million private placement offering. The company known for various products with cannabinoid and other natural ingredients launched the private placement via the DealSquare platform, which is supported by NEO and DealMaker technology. read more

Aleafia Health Presents Debuts High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. (TSX: AH) (OTCQX: ALEAF) is launching high potency CBD 50 oils. The cannabis company crafted SymblTM High CBD 50 and EmblemTM CBD 50 to meet the needs of both adult-use consumers and medical patients, respectively. read more